Back to Authors
0000-0002-7540-5315
Mayo Clinic
Target PharmaSolutions, Inc. (United States)
Future Rare Diseases | November 10, 2023 | Volume: 4 | Issue: 1 | Pages: No page available
10.2217/frd-2023-0016